Cart
sales@molnova.com
DQP 1105
CAS No. 380560-89-4
DQP 1105( —— )
Catalog No. M27625 CAS No. 380560-89-4
DQP 1105 is an NMDA receptor antagonist inhibiting receptor function more potently with glutamate.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 28 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 84 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 247 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDQP 1105
-
NoteResearch use only, not for human use.
-
Brief DescriptionDQP 1105 is an NMDA receptor antagonist inhibiting receptor function more potently with glutamate.
-
DescriptionDQP 1105 is an NMDA receptor antagonist inhibiting receptor function more potently with glutamate.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNMDAR
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380560-89-4
-
Formula Weight558.432
-
Molecular FormulaC29H24BrN3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (17.91 mM)
-
SMILESCc1ccc2=NC(=O)[C@@H](C3=NN([C@H](C3)c3ccc(Br)cc3)C(=O)CCC(O)=O)C(c3ccccc3)=c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gu J, et al. Drug-target network and polypharmacology studies of a Traditional Chinese Medicine for type II diabetes mellitus. Comput Biol Chem. 2011 Oct 12;35(5):293-7.
molnova catalog
related products
-
Ibotenic acid
Ibotenic acid has agonist activity at both the NMDA and trans-ACPD or metabotropic quisqualate receptors.
-
Tiletamine hydrochlo...
Proposed anesthetic with possible anticonvulsant and sedative properties.
-
ALDH3A1-IN-1
ALDH3A1-IN-1 (Compound 18) is a potent ALDH3A1 inhibitor with an IC 50 of 1.61 μM. It is more effective than DEAB against patient-derived primary prostate tumor epithelial cells, both as a single agent and in combination with docetaxel .
